Literature DB >> 500893

Potential use of 1,25-dihydroxycholecalciferol for prevention of parturient paresis.

D R Gast, R L Horst, N A Jorgensen, H F DeLuca.   

Abstract

Twelve cows, at least third parity, were assigned randomly to either a control or treatment group. Treated cows received .4 mg of the vitamin D metabolite, 1,25-dihydroxycholecalciferol intramusculary in 5 ml corn oil. Intramuscular injections were started 5 days before predicted calving with reinjections every 5 days until calving. Incidence of parturient paresis was 0 and 33% (2 of 6) in the treated and control groups. Response to treatment was rapid with elevated calcium in serum approximately 12 h postinjection. Treatment maintained or elevated calcium and phosphorus concentrations in serum during the critical period, 24 h pre- to 48 h postpartum, when milk fever is most likely to occur. There was, however, no significant difference between treatments at 72 h postpartum. Based on these observations 1,25-dihydroxycholecalciferol holds promise as a preventative of parturient paresis; however, further studies are needed on application and safety.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500893     DOI: 10.3168/jds.S0022-0302(79)83364-0

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  2 in total

1.  Oral 1,25-dihydroxyvitamin D3 in prevention of milk fever.

Authors:  K Hove; T Kristiansen
Journal:  Acta Vet Scand       Date:  1984       Impact factor: 1.695

Review 2.  Adapting to the transition between gestation and lactation: differences between rat, human and dairy cow.

Authors:  Ronald L Horst; Jesse P Goff; Timothy A Reinhardt
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-04       Impact factor: 2.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.